Wierzbicki, AS
10  Ergebnisse:
Personensuche X
?
2

Prescribing high-dose lipid-lowering therapy early to avoid..:

Ara, R ; Pandor, A ; Stevens, J...
European Journal of Preventive Cardiology.  19 (2011)  3 - p. 474-483 , 2011
 
?
4

Growth hormone increases VLDL apolipoprotein B100 secretion..:

Christ, ER ; Cummings, MH ; Albany, E...
Growth Hormone & IGF Research.  8 (1998)  4 - p. 326 , 1998
 
?
5

Acute kidney injury: prevention, detection, and management...:

Barrett, T ; Khwaja, A ; Carmona, C...
https://www.repository.cam.ac.uk/handle/1810/309827.  , 2021
 
?
6

Elevated Lipoprotein(a): Background, Current Insights and F..:

Handhle A ; Viljoen A ; Wierzbicki AS
https://www.dovepress.com/elevated-lipoproteina-background-current-insights-and-future-potential-peer-reviewed-fulltext-article-VHRM.  , 2021
 
?
9

Volanesorsen in the Treatment of Familial Chylomicronemia S..:

Esan O ; Wierzbicki AS
https://www.dovepress.com/volanesorsen-in-the-treatment-of-familial-chylomicronemia-syndrome-or--peer-reviewed-article-DDDT.  , 2020
 
?
10

Predicting major adverse cardiovascular events for secondar..:

Akyea, RK ; Leonardi-Bee, J ; Asselbergs, FW...
https://discovery.ucl.ac.uk/id/eprint/10107315/1/e034564.full.pdf.  , 2020
 
1-10